BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients
Open Access
- 11 April 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (4) , e0153319
Abstract
The BRAF V600E and telomerase reverse transcriptase (TERT) promoter mutations have been reported in papillary thyroid carcinoma (PTC). The aim of this retrospective cross-sectional study was to add further information regarding the prevalence of the BRAF V600E and TERT promoter mutations in Chinese PTC and their clinicopathological associations. We detected the BRAF V600E mutation and TERT promoter mutations in 455 Chinese PTC patients and analyzed the association of these mutations with several clinicopathological features. The BRAF V600E mutation was detected in 343 (75.4%) of 455 cases and was significantly associated with older age (p<0.001) and conventional subtype (p = 0.003). TERT promoter mutations were detected in 19 (4.4%) of 434 PTCs and were associated with older age (p<0.001), larger tumor size (p = 0.024), and advanced TNM stage(p<0.001). Of the 19 patients that were positive for TERT promoter mutations, 18 (94.7%) also harbored the BRAF V600E mutation. We determined the prevalence and clinicopathological associations of BRAF V600E and TERT promoter mutations in Chinese PTC patients. TERT promoter mutations but not the BRAF V600E mutation were associated with more advanced TNM stage upon diagnosis.Keywords
Funding Information
- Beijing Key Laboratory of Head and Neck Molecular Diagnostic Pathology
This publication has 23 references indexed in Scilit:
- TERT promoter mutations are associated with distant metastases in papillary thyroid carcinomaEuropean Journal of Endocrinology, 2015
- Association ofTERTPromoter Mutation 1,295,228 C>T WithBRAFV600E Mutation, Older Patient Age, and Distant Metastasis in Anaplastic Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2015
- Highly prevalentTERTpromoter mutations in bladder cancer and glioblastomaCell Cycle, 2013
- Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk FactorsJournal of Cancer Epidemiology, 2013
- Both BRAF V600E Mutation and Older Age (≥65 Years) are Associated with Recurrent Papillary Thyroid CancerAnnals of Surgical Oncology, 2011
- The Most Commonly Occurring Papillary Thyroid Cancer in the United States Is Now a Microcarcinoma in a Patient Older than 45 YearsThyroid®, 2011
- A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samplesJournal of Experimental & Clinical Cancer Research, 2010
- Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroidCancer, 2007
- Telomeres and human disease: ageing, cancer and beyondNature Reviews Genetics, 2005
- BRAF mutations in an Italian cohort of thyroid cancersClinical Endocrinology, 2004